Guardian Pharmacy Services (GRDN) Common Equity (2023 - 2026)

Guardian Pharmacy Services has disclosed Common Equity across 4 years of filings, most recently posting $232.4 million for Q1 2026.

• Common Equity for Q1 2026 came in at $232.4 million, up 42.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $232.4 million (up 42.4% YoY), and the FY2025 annual result was $217.9 million, up 45.31% from the prior year.
• Common Equity came in at $232.4 million for Q1 2026 at Guardian Pharmacy Services, up from $217.9 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $232.4 million in Q1 2026 to a low of $56.6 million in Q1 2024.
• The 4-year median for Common Equity is $150.0 million (2024), against an average of $136.9 million.
• Across the five-year window, Common Equity jumped 214.04% in 2025 and surged 42.4% in 2026, its largest moves.
• Guardian Pharmacy Services' Common Equity stood at $59.9 million in 2023, then surged by 150.55% to $150.0 million in 2024, then soared by 45.31% to $217.9 million in 2025, then climbed by 6.65% to $232.4 million in 2026.
• The last three Common Equity figures came in at $232.4 million (Q1 2026), $217.9 million (Q4 2025), and $195.5 million (Q3 2025), per Business Quant data.